Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way
https://doi.org/10.15829/1560-4071-2020-3839
Abstract
The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
About the Authors
F. CosentinoSweden
Francesco Cosentino, Cardiology Unit, Department of Medicine Solna
Solna, 171 76 Stockholm
P. J. Grant
United Kingdom
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way
V. Aboyans
France
G. J. Bailey
United Kingdom
А. Ceriello
Italy
V. Delgado
Netherlands
M. Federici
Italy
G. Filippatos
Greece
D. E. Grobbee
Netherlands
T. В. Hansen
Denmark
H. V. Huikuri
Finland
I. Johansson
Sweden
P. Jüni
Canada
M. Lettino
Italy
N. Marx
Germany
L. G. Mellbin
Sweden
C. J. Östgren
Sweden
B. Rocca
Italy
M. Roffi
Switzerland
N. Sattar
United Kingdom
P. M. Seferović
Czechoslovakia
M. Sousa-Uva
Portugal
P. Valensi
France
D. C. Wheeler
United Kingdom
Review
For citations:
Cosentino F., Grant P.J., Aboyans V., Bailey G.J., Ceriello А., Delgado V., Federici M., Filippatos G., Grobbee D.E., Hansen T.В., Huikuri H.V., Johansson I., Jüni P., Lettino M., Marx N., Mellbin L.G., Östgren C.J., Rocca B., Roffi M., Sattar N., Seferović P.M., Sousa-Uva M., Valensi P., Wheeler D.C. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way. Russian Journal of Cardiology. 2020;25(4):3839. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3839